InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,968.40
(
-1.24%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.27
(
1.49%
)
Bitcoin
60,113.74
(
-4.82%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: T_T23 post# 74332

Tuesday, 05/21/2013 11:15:42 PM

Tuesday, May 21, 2013 11:15:42 PM

Post# of 158400
Correct Q2 was the MIN technology of the breast cancer vaccine announced a few weeks ago. Q2 runs April, may, June. FDA decision on questions is Q3 which is July,August,September.

Milestones Achieved
HemaXellarate product developed
Preclinical data published
Principle Investigator recruited
FDA # granted
Second program conceptualized, discussions ongoing for licensing
Upcoming Milestones
Response to FDA questions: Q3 2013
Initiate HemaXellerate trial: Q4 2013
Complete HemaXellerate trial: Q4 2014-Q2 2015
In license Min technology: Q2 2013
File IND on Min technology: Q4 2013
Initiate clinical trial on Min technology: Q4 2013
Complete clinical trial on Min technology: Q4 2014-Q2 2015
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up